For five years, every GLP-1 weight-loss medication meant one thing: a weekly injection. Some people were fine with that. Many others — people who are needle-phobic, who travel constantly, who simply don't want to inject themselves — stayed on the sidelines waiting for another option.
That option arrived in January 2026. The Wegovy pill — oral semaglutide 25mg, taken once daily — is now available at more than 70,000 US pharmacies. And at $149-$299/month cash pay, it's the most affordable branded GLP-1 on the market.
Here's everything you need to know.
What is the Wegovy pill?
It's the exact same active ingredient as Wegovy injections and Ozempic — semaglutide — in a daily oral tablet. The FDA approved it on December 22, 2025, making it the first oral GLP-1 receptor agonist specifically approved for weight management.
Important distinction: this is NOT the same as Rybelsus, which is also oral semaglutide but approved for type 2 diabetes at lower doses (3mg, 7mg, 14mg). The Wegovy pill is a 25mg tablet — nearly double Rybelsus's maximum dose — specifically approved and dosed for weight loss.
How effective is it?
The OASIS 4 trial enrolled 307 adults with obesity or overweight (without diabetes) and compared oral semaglutide 25mg to placebo over 64 weeks (Wharton et al., 2024).
Key results:
- Mean weight loss: 13.6% (intention-to-treat) and 16.6% with full treatment adherence
- One-third of adherent participants lost 20% or more of their body weight
- 71.1% of participants with prediabetes at baseline achieved normal blood glucose
- Significant improvements across cardiovascular risk markers
How does that compare to the injections?
- Wegovy injection 2.4mg: ~15% weight loss (STEP 1)
- Wegovy pill 25mg: ~16.6% weight loss with adherence (OASIS 4)
- Wegovy HD injection 7.2mg: ~20.7% weight loss (STEP UP)
The pill is roughly comparable to the standard-dose injection. It's less effective than the new high-dose injection (Wegovy HD), but for many people the convenience of a daily pill versus a weekly injection makes it the preferred choice.
How to take it
This is important, because oral semaglutide has specific timing requirements that affect how well it works.
Take it first thing in the morning on an empty stomach. You need to have fasted overnight. Swallow the tablet whole with a small amount of plain water — no more than about 120ml (half a glass). Then wait at least 30 minutes before eating, drinking anything other than plain water, or taking other medications.
The 30-minute fasting window matters. Semaglutide is a peptide, and food in your stomach significantly reduces absorption. Skipping or shortening this window means you're getting less of the active drug.
For some people, this timing requirement is a minor inconvenience. For others — particularly those who take morning medications with food, or who have schedules that make a predictable morning routine difficult — it's a genuine consideration.
It's worth noting that Eli Lilly's oral GLP-1 candidate, orforglipron, doesn't require fasting or water-timing restrictions. If orforglipron receives FDA approval (expected in 2026), that convenience advantage could matter for people choosing between oral GLP-1 options.
The dose escalation schedule
Like all GLP-1 medications, you don't start at the full dose. The Wegovy pill uses a 12-week escalation:
- Weeks 1-4: 3mg daily
- Weeks 5-8: 7mg daily
- Weeks 9-12: 14mg daily
- Week 13 onward: 25mg daily
This gradual ramp-up is designed to minimise gastrointestinal side effects. Rushing the escalation increases the risk of nausea and vomiting. Your doctor may slow the schedule if side effects are significant.
Side effects
The side effect profile mirrors injectable semaglutide — because it's the same drug. Gastrointestinal effects dominate:
- Nausea (most common, especially during dose escalation)
- Diarrhoea
- Vomiting
- Constipation
- Abdominal pain
These are generally mild to moderate and improve over time. The GI tolerability pattern seen across the SURMOUNT trials — nausea peaking during dose increases and resolving at stable doses — applies equally to oral semaglutide (Rubino et al., 2025).
One consideration specific to the pill: because you take it daily rather than weekly, some people find the side effects are more evenly distributed rather than concentrated on the day or two after an injection. Whether that's better or worse is individual.
The cost advantage
This is where the Wegovy pill really stands out.
Cash-pay pricing: $149/month (starting dose) to $299/month (maintenance dose). Compare that to:
- Wegovy injection: ~$1,300/month list price
- Zepbound injection: ~$1,000-1,100/month list price
- Ozempic injection: ~$900-1,000/month list price
Even with manufacturer discount programmes and the government-negotiated price reductions, the Wegovy pill's cash price undercuts virtually everything else on the market.
Insurance coverage adds another layer. Some insurers cover the pill under the same terms as the injection. Others may have different formulary placement. Check with your specific plan.
The affordability angle is significant because cost has been the single biggest barrier to GLP-1 access. Millions of people who could benefit from these medications have been priced out. A $149-$299/month option changes the equation dramatically.
Pill vs injection: making the choice
Choose the pill if:
- You're needle-phobic or simply prefer swallowing a tablet
- Cost is a primary concern (the pill is significantly cheaper)
- You're new to GLP-1 treatment and want to start with the least invasive option
- You travel frequently and don't want to deal with injection supplies, refrigeration, and airport security questions
- You want roughly equivalent results to standard-dose injections
Choose the injection if:
- You want the maximum available weight loss (Wegovy HD 7.2mg produces ~21%)
- The 30-minute fasting window doesn't fit your lifestyle
- You prefer once-weekly dosing over daily medication
- You've tried oral semaglutide and had absorption or GI issues specific to the pill
- You need the cardiovascular risk reduction indication (SELECT trial data is based on the injection)
A reasonable strategy: Start with the pill. If the results are good, stay on it. If you want more weight loss and can tolerate injections, discuss stepping up to injectable Wegovy (2.4mg or 7.2mg) with your doctor.
Where to get it
The Wegovy pill is available at over 70,000 US pharmacies including CVS and Costco, as well as select telehealth providers (Ro, LifeMD, Weight Watchers, GoodRx) and Novo Nordisk's NovoCare Pharmacy.
You need a prescription. No GLP-1 medication — pill or injection — is available over the counter. Talk to your doctor about whether you're a candidate based on your BMI, health history, and treatment goals.
The bottom line
The Wegovy pill is the most accessible GLP-1 weight-loss medication ever launched. A daily tablet, no needles, $149-$299/month cash pay, available at tens of thousands of pharmacies, with weight loss results that rival the standard-dose injection. It's not the most powerful GLP-1 option available — Wegovy HD and Zepbound produce more weight loss — but for millions of people who've been waiting for a GLP-1 they can actually afford and are willing to take, this is it.
Key Studies & References
-
Wharton et al. (2024) — The OASIS 4 trial: oral semaglutide 25mg achieved 16.6% mean weight loss at 64 weeks with full adherence in adults with obesity, with one-third losing ≥20%. The pivotal study behind the Wegovy pill's FDA approval. Read the full study
-
Wilding et al. (2021) — The STEP 1 trial showing injectable semaglutide 2.4mg (standard Wegovy) achieved 14.9% weight loss at 68 weeks — the comparison benchmark for the oral formulation. Read the full study
-
Wharton et al. (2025) — The STEP UP trial showing injectable semaglutide 7.2mg (Wegovy HD) achieved 20.7% weight loss, representing the maximum currently available semaglutide efficacy. Read the full study
-
Rubino et al. (2025) — GI tolerability analysis confirming the nausea-peaks-then-resolves pattern that applies across all semaglutide formulations and doses. Read the full study